Advertisement

Applied Biochemistry and Biotechnology

, Volume 187, Issue 4, pp 1344–1355 | Cite as

Establishment of a DGKθ Endogenous Promoter Luciferase Reporter HepG2 Cell Line for Studying the Transcriptional Regulation of DGKθ Gene

  • Linlin Shan
  • Dongyang Wang
  • Qinwen Mao
  • Haibin XiaEmail author
Article
  • 129 Downloads

Abstract

DGKθ protein expression levels are closely related to the development of diseases including diabetes, cancer, and neuronal disease. To investigate the transcriptional regulation of the DGKθ gene, we used CRISPR/Cas9 to generate a DGKθ endogenous promoter luciferase reporter HepG2 cell line, in which the endogenous DGKθ promoter controls the expression of the luciferase reporter gene. To test the cell line, FXR, the transcription factor for upregulating the expression of DGKθ gene, was used to validate the cell line. Furthermore, the reported agonists for the expression of DGKθ, cAMP and GW4064, the known inhibitor for DGKθ enzyme activity, R59949, and a potential regulator for DGKθ enzyme expression, EGCG (the major catechin in green tea), were applied to the reporter cell line. The results indicated that these reagents could significantly regulate the expression of reporter luciferase. Finally, four transcription factors (E2F1, c-Myc, USF1, and Bmal1) potentially binding to the DGKθ gene’s upstream promoter region were tested. DGKθ expression was upregulated by c-Myc and downregulated by E2F1, which was also confirmed in wild-type HepG2 cells. We found that the cell line’s luciferase activity was directly correlated with DGKθ endogenous promoter activity, suggesting that it is liable and sensitive for studying DGKθ transcriptional regulation. The study provides a useful tool for high-throughput drug screening for the treatment of DGKθ-involved diseases.

Keywords

CRISPR/Cas9 DGKθ Transcriptional regulation Green tea polyphenols EGCG HepG2 

Notes

Funding Information

This work was supported by the Fundamental Research Funds for Free Exploration Funds of Graduate Programs, Shaanxi Normal University (No. 2016TS058), and research grants to H.X. from the National Natural Science Foundation of China (No. 81471772 and No. 81773265) and Key Research and Development Plan of Shaanxi Province (No. 2018SF-106).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Supplementary material

12010_2018_2890_MOESM1_ESM.docx (15 kb)
ESM 1 (DOCX 15 kb)

References

  1. 1.
    Sakane, F., Imai, S., Kai, M., Yasuda, S., & Kanoh, H. (2007). Diacylglycerol kinases: why so many of them? Biochimica et Biophysica Acta, 1771, 93–806.CrossRefGoogle Scholar
  2. 2.
    Mérida, I., Avila-Flores, A., & Merino, E. (2008). Diacylglycerol kinases: at the hub of cell signalling. Biochemical Journal, 409(1), 1–18.CrossRefGoogle Scholar
  3. 3.
    Houssa, B., Schaap, D., van der Wal, J., Goto, K., Kondo, H., Yamakawa, A., Shibata, M., Takenawa, T., & van Blitterswijk, W. J. (1997). Cloning of a novel human diacylglycerol kinase (DGK theta) containing three cysteine-rich domains, a proline-rich region, and a pleckstrin homology domain with an overlapping Ras-associating domain. Journal of Biological Chemistry, 272(16), 10422–10428.CrossRefGoogle Scholar
  4. 4.
    Shulga, Y. V., Topham, M. K., Matthew, K. T., & Richard, M. E. (2011). Regulation and functions of diacylglycerol kinases. Chemical Reviews, 111(10), 6186–6208.CrossRefGoogle Scholar
  5. 5.
    Ohanian, J., & Ohanian, V. (2001). Sphingolipids in mammalian cell signaling. Cellular and Molecular Life Sciences, 58(14), 2053–2068.CrossRefGoogle Scholar
  6. 6.
    Topham, M. K. (2006). Signaling roles of diacylglycerol kinases. Journal of Cellular Biochemistry, 97(3), 474–484.CrossRefGoogle Scholar
  7. 7.
    Ueda, S., Tu-Sekine, B., Yamanoue, M., Raben, D. M., & Shirai, Y. (2013). The expression of diacylglycerol kinase theta during the organogenesis of mouse embryos. BMC Developmental Biology, 13(1), 35.CrossRefGoogle Scholar
  8. 8.
    Kanoh, H., Yamada, K., & Sakane, F. (2002). Diacylglycerol kinases: emerging downstream regulators in cell signaling systems. Journal of Biochemistry, 131(5), 629–633.CrossRefGoogle Scholar
  9. 9.
    Wattenberg, B. W., Pitson, S. M., & Raben, D. M. (2006). The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. Journal of Lipid Research, 47(6), 1128–1139.CrossRefGoogle Scholar
  10. 10.
    Kim, H., & Kim, J. S. (2014). A guide to genome engineering with programmable nucleases. Nature Reviews Genetics, 15(5), 321–334.CrossRefGoogle Scholar
  11. 11.
    Szymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., & Vignali, D. A. A. (2004). Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nature Biotechnology, 22(5), 589–594.CrossRefGoogle Scholar
  12. 12.
    Xiao, D., Zhang, W., Li, Y., Liu, K., Zhao, J., Sun, X., Shan, L., Mao, Q., & Xia, H. (2016). A novel luciferase knock-in reporter system for studying transcriptional regulation of the human Sox2 gene. Journal of Biotechnology, 219, 110–116.CrossRefGoogle Scholar
  13. 13.
    Cai, K., & Sewer, M. B. (2013). Diacylglycerol kinase-θ couples farnesoid X receptor-dependent bile acids signaling to Akt activation and glucose homeostasis in hepatocytes. Biochemical Journal, 454(2), 267–274.CrossRefGoogle Scholar
  14. 14.
    Cai, K., Sewer, M.B. (2013). cAMP-stimulated transcription of DGKθ requires steroidogenic factor 1 and sterol regulatory element binding protein 1. Journal of Lipid Research, 54(8), 2121–2132.Google Scholar
  15. 15.
    Baldanzi, G., Alchera, E., Imarisio, C., Gaggianesi, M., Dal Ponte, C., Nitt, M., Domenicott, C., WJ van Blitterswijk, E. A., Graziani, A., & Carini, R. (2010). Negative regulation of diacylglycerol kinase θ mediates adenosine-dependent hepatocyte preconditioning. Cell Death and Differentiation, 17(6), 1059–1068.CrossRefGoogle Scholar
  16. 16.
    Li, G., Lin, W., Araya, J. J., Chen, T., Timmermann, B. N., & Guo, G. L. (2012). A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor. Toxicology and Applied Pharmacology, 258(2), 268–274.CrossRefGoogle Scholar
  17. 17.
    Cai, K., Lucki, N. C., Sewer, M. B. (2014). Silencing diacylglycerol kinase-theta expression reduces steroidogenic capacity in human adrenocortical cells. Biochimica et Biophysica Acta, 1841(4), 552–562.Google Scholar
  18. 18.
    Raben, D. M., & Tu-Sekine, B. (2008). Nuclear diacylglycerol kinases: regulation and roles. Frontiers in Bioscience, 13(13), 590–597.CrossRefGoogle Scholar
  19. 19.
    Clarke, M., & Dodson, P. M. (2007). PKC inhibition and diabetic microvascular complications. Best Practice & Research. Clinical Endocrinology & Metabolism, 21(4), 573–586.CrossRefGoogle Scholar
  20. 20.
    Zhang, J., Zhao, J., Zheng, X., Cai, K., Mao, Q., & Xia, H. (2018). Establishment of a novel hepatic steatosis cell model by Cas9/sgRNA-mediated DGKθ gene knockout. Molecular Medicine Reports, 17(2), 2169–2176.Google Scholar
  21. 21.
    El-Khairi, R. (2012). Steroidogenic factor-1 and human disease. Seminars in Reproductive Medicine, 30(5), 374–381.CrossRefGoogle Scholar
  22. 22.
    Dang, C. V., Resar, L. M. S., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D., & Zeller, K. (1999). Function of the c-Myc oncogenic transcription factor. Experimental Cell Research, 253(1), 63–77.CrossRefGoogle Scholar
  23. 23.
    Lai, Q., Giralt, A., Le May, C., Zhang, L., Cariou, B., Denechaud, P.-D., & Fajas, L. (2017). E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver. JCI Insight, 2(10), e89729.CrossRefGoogle Scholar
  24. 24.
    Denechaud, P. D., Lopez-Mejia, I. C., & Fajas, L. (2016). Cell cycle regulators CDK4 and E2F1 control glucose and lipid homeostasis. Medical Science (Paris), 32(10), 815–818.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Laboratory of Gene Therapy, Department of Biochemistry, College of Life SciencesShaanxi Normal UniversityXi’anPeople’s Republic of China
  2. 2.Department of PathologyNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations